MedPath

Role of Imaging to Predict the Deep Surgical Margin in Gingivobuccal Complex Tumors

Not Applicable
Conditions
Gingival Cancer
Buccal Mucosa Cancer
Registration Number
NCT03137953
Lead Sponsor
HealthCare Global Enterprise Ltd.
Brief Summary

In gingivobuccal complex tumors, the skin margin is assessed by palpation (skin pinch test). There is no objective method of assessment of skin margin. This study is to evaluate the role of computed tomography/MRI with contrast in assessing the deep surgical margin.

Detailed Description

The patients of buccal mucosa squamous cell carcinomas after histopathological confirmation are selected for the study. As a routine computed tomography imaging/MRI with contrast will be done preoperatively.

The involvement of the skin is assessed by the palpation (skin pinch test). In imaging, the distance between the base of the tumour and the skin of the cheek is measured. If the distance between the base of the tumour and the skin is more than 5mm, then the skin is spared and the tumour is excised with 5 mm margin, if the distance is less than 5mm, then the skin is excised along with the tumour. The specimen will be sent for histopathological examination, and the depth of invasion of the tumour is measured and the clearance of the deep surgical margin is assessed.

The difference between clinical examination and imaging and histopathological confirmation of the specimen in determining the number of cases where skin preservation is done is assessed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients of buccal mucosa squamous cell carcinomas of stage 1,2 and 3 are included in the study
  • Patient of all age groups are included in the study
  • Both males and females are included in the study
Exclusion Criteria
  • Patients with buccal mucosa carcinomas, in whom the tumour is involving/fungating through the skin.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Proportion of patients undergoing skin preservation surgeriesData would be obtained on the day of Surgery

Proportion of subjects who are to undergo skin preservation surgeries

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

HealthCare Global Enterprises Ltd

🇮🇳

Bangalore, Karnataka, India

HealthCare Global Enterprises Ltd
🇮🇳Bangalore, Karnataka, India
Vishal US Rao, MS
Contact
00919739774949
drvishalrao@yahoo.com
Sataksi Chatterjee, MS
Contact
00918971966903
sataksis2007@gmail.com
Sowjanya Gandla, MS
Sub Investigator
Shivakumar Swamy, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.